Susan Hasty, Publisher
Table of Contents . . . February 15th, 1999Non-Subscriber - Summaries Only
Drug Development - Potential Acyclovir Prodrugs Synthesized
Pharmacokinetics - D-D4FC Values Determined in Rhesus Monkeys
Therapy - SpC3 Activity Studied
Therapy (HCV) - IFN Impact on Liver Fibrosis Progression Examined
Therapy (TB) - Benefits of Liposomal Amikacin Against MDR-TB Unclear
Virology - New Agent Shows Activity Against Poliovirus
End-Stage Liver Disease - Transplantation Achieved in HIV Infected Hemophiliac
Animal Models (HBV) - Trimera Disease Model Developed for Hepatitis B
Etiology (HIV-1) - Scientists Discover Origin of HIV-1
HIV Vaccines - Studies Offer Clues to Vaccine Design and Safety
Industry News (HSV Vaccine) - Herpes Vaccine Effective in Animals
Industry News (Protease Inhibitors) - Clinical Trial Results Suggest Agenerase Is Potent, Easy to Take
Protease Inhibitors (Viracept) - Results Presented for Patients Switching to Other Combination Therapies
Protease Inhibitors (Viracept) - Therapy Produces Anti-HIV Effects in Women
Risk Factors (HIV) - Doctors Fear HIV Patients Getting Careless
Dosage Change (Effectiveness) - "An Open Label, Randomized Trial Switching Nelfinavir Dosing from TID to BID: Six Month Report."
Dosage Change (Effectiveness) - "Effect of Change from TID to BID Nelfinavir (NFV) on Viral Load and CD4 Count."
AIDS Therapies (Bone Homeostasis) - "Decreased Bone Formative and Enhanced Resorptive Markers in Human Immunodeficiency Virus Infection: Indication of Normalization of the Bone-Remodeling Process During Highly Active Antiretroviral Therapy."
Immunology (Interferon Expression) - "A Bioassay for Interferon Type I Based on Inhibition of Sendai Virus Growth."
Vaccine Efficacy (Influenza) - "Antibody Response to 1995-1996 Influenza Vaccine in Institutionalized and Non-Institutionalized Elderly Women."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.